Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Relapsed and/or Refractory Acute Lymphoblastic Leukemia”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)UnknownNCT04037566
What this trial is testing

CRISPR (HPK1) Edited CD19-specific CAR-T Cells (XYF19 CAR-T Cells) for CD19+ Leukemia or Lymphoma.

Who this might be right for
Leukemia Lymphocytic Acute (ALL) in RelapseLeukemia Lymphocytic Acute (All) RefractoryLymphoma, B-Cell+1 more
Xijing Hospital 40
Early research (Phase 1)Study completedNCT00045266
What this trial is testing

VEGF Trap in Treating Patients With Solid Tumors or Non-Hodgkin's Lymphoma

Who this might be right for
LymphomaUnspecified Adult Solid Tumor, Protocol Specific
Regeneron Pharmaceuticals
Not applicableStudy completedNCT00993694
What this trial is testing

Methemoglobinemia in Young Patients With Hematologic Cancer or Aplastic Anemia Treated With Dapsone

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+6 more
Vanderbilt University 41
Testing effectiveness (Phase 2)Ended earlyNCT00625729
What this trial is testing

Donor Natural Killer Cell Infusion, Rituximab, Aldesleukin, and Chemotherapy in Treating Patients With Relapsed Non-Hodgkin Lymphoma or Chronic Lymphocytic Leukemia

Who this might be right for
LeukemiaLymphoma
Masonic Cancer Center, University of Minnesota 6
Early research (Phase 1)Ended earlyNCT00068302
What this trial is testing

Sirolimus in Treating Young Patients With Relapsed or Refractory Acute Leukemia or Non-Hodgkin's Lymphoma

Who this might be right for
LeukemiaLymphoma
Children's Hospital of Philadelphia 10
Not applicableStudy completedNCT00003837
What this trial is testing

506U78 in Treating Patients With Relapsed or Refractory T-cell Acute Lymphoblastic Leukemia or T-cell Lymphoblastic Lymphoma

Who this might be right for
LeukemiaLymphoma
National Cancer Institute (NCI) 25
Testing effectiveness (Phase 2)Study completedNCT01279473
What this trial is testing

Study to Evaluate Nilotinib in Adult Patients With Imatinib-resistant or Imatinib-intolerant Chronic Myelogenous Leukemia (CML), or Relapse/Refractory Ph+ Acute Lymphoblastic Leukemia (ALL) (Extension Study)

Who this might be right for
Chronic Myelogenous LeukemiaAcute Lymphoblastic Leukemia
Novartis Pharmaceuticals 42
Testing effectiveness (Phase 2)Ended earlyNCT02129062
What this trial is testing

Ibrutinib in Treating Patients With Relapsed or Refractory B-cell Acute Lymphoblastic Leukemia

Who this might be right for
Adult B Acute Lymphoblastic LeukemiaAdult B Acute Lymphoblastic Leukemia With t(9;22)(q34;q11.2); BCR-ABL1Recurrent Adult Acute Lymphoblastic Leukemia
National Cancer Institute (NCI) 3
Testing effectiveness (Phase 2)Ended earlyNCT02089230
What this trial is testing

MEK Inhibitor 162 Relapsed and/or Refractory Acute Myeloid Leukemia (AML) and Poor Prognosis, Not Suitable for or Unwilling to Receive Standard Therapy

Who this might be right for
Leukemia
M.D. Anderson Cancer Center 19
Early research (Phase 1)WithdrawnNCT05961696
What this trial is testing

A Phase I Study of Mosunetuzumab for Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia

Who this might be right for
Refractory B-cell Acute Lymphoblastic Leukemia
M.D. Anderson Cancer Center
Early research (Phase 1)UnknownNCT05679687
What this trial is testing

ThisCART19A Bridging to alloHSCT for R/R B-ALL

Who this might be right for
CARRefractory Acute Lymphoblastic LeukemiaRelapsed Adult ALL
The First Affiliated Hospital of Soochow University 20
Early research (Phase 1)Study completedNCT00110071
What this trial is testing

Iodine I 131 Tositumomab and Fludarabine Phosphate in Treating Older Patients Who Are Undergoing an Autologous or Syngeneic Stem Cell Transplant for Relapsed or Refractory Non-Hodgkin's Lymphoma

Who this might be right for
Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid TissueNodal Marginal Zone B-cell LymphomaRecurrent Adult Burkitt Lymphoma+12 more
Fred Hutchinson Cancer Center 38
Testing effectiveness (Phase 2)Ended earlyNCT03094611
What this trial is testing

Inotuzumab Ozogamicin in Treating Patients With Relapsed or Refractory CD22 Positive Acute Lymphoblastic Leukemia

Who this might be right for
CD22 PositiveRecurrent Acute Lymphoblastic LeukemiaRefractory Acute Lymphoblastic Leukemia
M.D. Anderson Cancer Center 4
Large-scale testing (Phase 3)Study completedNCT00782145
What this trial is testing

A Web-Based Stem Cell Transplant Support System or Standard Care in Young Patients Undergoing Stem Cell Transplant and Their Families

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+6 more
Tufts Medical Center 198
Early research (Phase 1)Ended earlyNCT00112619
What this trial is testing

Topotecan in Treating Young Patients With Neoplastic Meningitis Due to Leukemia, Lymphoma, or Solid Tumors

Who this might be right for
Brain and Central Nervous System TumorsCarcinoma of Unknown PrimaryLeukemia+2 more
Pediatric Brain Tumor Consortium 19
Early research (Phase 1)Study completedNCT00002765
What this trial is testing

Immunotoxin in Treating Patients With Leukemia or Lymphoma

Who this might be right for
LeukemiaLymphoma
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Study completedNCT01656031
What this trial is testing

A Phase II Open-Label Study of High-Dose Cytarabine and Clofarabine in Adult Patients With Refractory or Relapsed Acute Myelogenous Leukemia or Refractory or Relapsed Acute Lymphoblastic Leukemia

Who this might be right for
Leukemia
Wake Forest University Health Sciences 39
Not applicableStudy completedNCT00897767
What this trial is testing

Collecting Tissue Samples From Patients With Leukemia or Other Blood Disorders Planning to Enroll in an ECOG Leukemia Treatment Clinical Trial

Who this might be right for
LeukemiaLymphoma
Eastern Cooperative Oncology Group 1,873
Testing effectiveness (Phase 2)Ended earlyNCT00006092
What this trial is testing

Arsenic Trioxide for Induction Therapy of Adult Patients With Leukemia

Who this might be right for
Leukemia
H. Lee Moffitt Cancer Center and Research Institute 2
Early research (Phase 1)Looking for participantsNCT06136364
What this trial is testing

CD7 CAR-T in Adults With Relapsed or Refractory T-LBL/ALL Clinical Study

Who this might be right for
T-lymphoblastic LymphomaT-ALL
Hebei Senlang Biotechnology Inc., Ltd. 9
Next Page